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Functionalization of Resorcinarenes and Study of Antimicrobial Activity 
KiranKirti Muppalla 
ABSTRACT 
 
Cavitands are very important class of compounds in supramolecular chemistry. These 
molecules contain rigid enforced cavity,and have attracted considerable attention in 
supramolecular chemistry as building blocks for the construction of carcerands, 
hemicarcerands, and other host guests complexes. Nearly 40 years ago, Niederl and 
Vogel laid foundation for the study of such type of condensation reactions. In our 
laboratory we are involved in synthesis of resorcinarenes with readily available substrates 
such as resorcinol and aldehydes to form a cyclic tetramer.  
Herein, I present detailed studies about the functionalization of the synthesized 
tetramers and their antimicrobial activity.  Octahydroxy resorcinarenes were synthesized 
and perallylated which served as acyclic diene precursors for ring closing metathesis 
reaction. Studies were carried out to see effect of C-2 substituent of resorcinol and effect 
of aryl substituents, and aliphatic substituents on ring closing metathesis. This thesis 
describes the synthesis of bridged resorcinarenes and study of antimicrobial activity of 
resorcinarenes. 
 
 
 xi
 
 
 
 
 
 
CHAPTER 1. INTRODUCTION 
 
1.1. Introduction to Resorcinarenes 
Cavitands namely bridged resorcinarenes can be defined as molecules that have 
constrained structure large enough to host other molecules1,2. The original term cavitand 
was coined by noble laureate D.J.Cram, who defined cavitands as “synthetic organic 
compounds with enforced cavities large enough to complex complementary organic 
compounds or ions”1. They have been established as fruitful platform for the attachment 
of different ligating sites giving rise to ionophores for anions, cations, neutral 
molecules.4,5,6  Resorcinarenes such as 1 (Figure 1) are cyclic tetramers readily formed 
by the acid-catalyzed condensation of resorcinol with aldehydes.1,3 Resorcinarenes have 
been widely exploited as a basis for making macrocyclic host molecules in a variety of 
supramolecular systems, These cavitands have the ability to encapsulate and stabilize 
guests molecules, and to catalyze chemical transformations within their “microreactor" 
cage like structure.7  
                              In 1870, Adolf Von Baeyer observed a red-colored solution upon 
addition of concentrated sulfuric acid to an ethanolic solution of benzaldehyde and 
resorcinol.8 The red-colored solution yielded, in several days, a crystalline compound. In 
1883, Michael determined that the crystalline compound formed was from an equal 
number of benzaldehyde and resorcinol molecules with loss of water molecules.9 In 1940, 
Vogel and Niederl10 prepared the crystalline compound described by Baeyer and its 
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peracetate derivative. Molecular weight determinations of the crystalline compound and 
the peracetate derivative led them to establish the ratio of the resorcinol and the aldehyde 
to be 4:4, i.e., each molecule of the resorcinarene contained four molecules of the 
resorcinol with four molecules of the aldehyde, with loss of 4 molecules of water.11 The 
crystal structure of the resorcinarene was first solved by Erdtman and coworkers in 
1968.12  
 
 
HO OH
HO
HOR1R1 R1R1 OH HO OH
OH 
 
R RR R
 
                                                 R1 = H,  CH3, OH, Br, NO2 
                    R = Aliphatic or Aromatic substituents 
                                            Figure 1. Structure of Resorcinarene 
Macrocyclic ring of resorcinarenes can adopt five symmetrical arrangements, 
namely, crown, chair, boat, diamond and saddle (Figure 2).1a,b,12  However boat and chair 
are the two majorly preferred conformations depending on different R and R1 substituents 
on the cavitands.13
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Figure 2. Conformations of Resorcinarene (Top View) 
 
Resorcinarene cavitands are of particular interest due to their robust cavity which can be 
modified at the upper or lower rims without compromising the structural integrity of the 
inner cavity.14,1c Intramolecular cyclizations, linkage of the neighboring phenolic groups 
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on the adjacent phenyl rings, are the method of choice which can lead to 
conformationally locked "bowl shaped" resorcinarene cavitands.15 Owing to the ease of 
their synthesis , resorcinarenes often have been used as a starting material for a wide 
variety of compounds.16 Additionally, in these molecules the upper rim can be varied by 
different functionalities, i.e., substituents can be added between two electron releasing 
hydroxyl groups. Further modification have been reported with bridging groups, e. g., 
methylene bridged, ethylene bridged, and propylene bridged compounds have been 
prepared.17    
Resorcinarenes can be prepared in high yields by condensation of resorcinol and 
aldehydes without using any template or high dilution techniques. In recent years, other 
methods of preparation of resorcinarenes have been developed. Notably, Lewis acid 
catalyzed tetramerization of cinnamates to a series of C-alkyl resorcinarenes has been 
developed by Bruno Botta et al18.  Specifically, 2, 4-dimethoxycinnamic acid was used as 
starting material under carefully controlled reaction conditions employing BF3 as a lewis 
acid catalyst.  This method allows preparation of the resorcinarenes with different 
functionalities at the lower rim, which require multi-step approach by original 
condensation reaction. 
Ring closing metathesis (RCM) is increasingly becoming an efficient approach 
for the synthesis of medium to large ring systems. Advancement in the design of the 
catalyst leading to their remarkable functional group tolerance, operational simplicity, 
high stability and commercial availability has greatly contributed to the popularity of the 
RCM reaction.  In a recent report McKervey19 and Chen20 have reported use of RCM in 
bis- and tetracalix[4]arenes.  The bridging reaction, tandem RCM ring closing, can be 
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used to manipulate the cavity size and hence can be used to modify the properties of the 
cavitand. However, there has been no report in literature of RCM reaction to manipulate 
the cavity size in resorcinarene cavitands. 
In chapter 2 I will describe our effort on RCM reaction on resorcinarene and 
its effect on the cavity size.  The ring closing metathesis reaction using Grubb’s catalyst 
(Gen I) was investigated on perallylated resorcinarenes, where allyl groups on adjacent 
phenyl rings serve as acyclic diene precursors, led to the formation of bridged 
resorcinarene cavitands. The diameter of the upper rim was thus enlarged and the cavity 
size can be further manipulated by functionalization. This report discusses in detail the 
effect of C-2 substituents of resorcinol along with effect of small chain aliphatic, long 
chain aliphatic, and aryl substituents on ring closing metathesis reaction. 
The pursuit of antimicrobially active compounds against a variety of 
microorganisms is an area of intense and important research.  Antimicrobial activity of 
calixarenes was tested by Lamartine21 et al in 2002.  They conducted preliminary 
screening of 57 calixarenes to assay their potential as antimicrobially active compounds 
against Corynebacterium fusarium.  Of these compounds tested, calixarenes which 
containing sulfonate group and hydroxyl group were found to exhibit antimicrobial 
activity.21  Surprisingly, there has been no report on antimicrobial activity of 
resorcinarenes in the literature.  In the chapter 3, I report the antimicrobial activity of 
resorcinarenes having different side chains, substitution groups against a diverse set of 
bacteria and yeasts.  
 5
  
 
CHAPTER 2 
SYNTHESIS OF RESORCINARENES 
 
2.1 Synthesis of Octahydroxy Resorcinarenes 
2.1a- Synthesis of Octahydroxy Resorcinarenes with aliphatic substituents (1-4) 
Resorcinarenes 1 and 2 were prepared by condensation of methyl resorcinol and 
acetaldehyde/heptaldehyde catalyzed by hydrochloric acid in ethanol (Scheme 1).  The 
reaction mixture was refluxed for 12hrs which led to precipitation of yellow-colored 
solids. Compounds 1 and 2 were isolated in 67% and 88% respectively. The 1H NMR 
spectrum of compound 1 in DMSO d6 recorded at 400MHz shows a single resonance for 
Ha at 4.4 ppm (benzylic proton), Hb at 8.6ppm (Hydroxy protons), Hc at 1.9ppm (ArCH3), 
Hd at 1.6ppm (CHCH3) (Figure 3) and Ha at 4.2 ppm for compound 2. The resonances 
match with literature reported values.1
 Resorcinarenes 3 and 4 were synthesized following a similar procedure except for 
the reaction temperature which was maintained at 45oC.  Products were precipitated in ice 
cold water as light yellow colored solids with 48% and 78% yields, respectively.  The 1H 
NMR spectra of compounds 3 and 4 was similar to compounds 1 and 2 except for 
resonance of methyl proton at 1.97 ppm. The 13C spectrum of these compounds were 
interpreted and they match with literature reported values.1  
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2.1b Synthesis of Octahydroxy Resorcinarenes with Aromatic substituents (5-8) 
In a procedure similar to that described for compounds 1-4, resorcinarenes 5 and 6 were 
prepared by condensation of methyl resorcinol and benzaldehyde/bromobenzaldehyde 
(Scheme 1). The reaction mixture was refluxed for 12hrs which led to precipitation of 
yellow-colored solids.  Resorcinarenes 5 and 6 were isolated in 88% and 90% yield, 
respectively. The 1H NMR spectra of compounds 5 and 6 in DMSO-d6, recorded at 400 
MHz, showed two resonances for Ha at 5.3 ppm and 6.1 ppm (Figure 4) suggesting two 
different chemical environment around Ha, i.e., the compounds 5 and 6 exists in the chair 
conformation. Literature reports on compound 5 and 6 have confirmed their chair 
conformation.1 Using a similar experimental procedure, the condensation of resorcinol 
with benzaldehyde /bromobenzaldehyde gave compounds 7 and 8 in 56% and 67% yield. 
The structure of the compound was confirmed from their 1H and 13C NMR spectral data 
and it was found to match with the data in literature.1 
R1
OHHO HO OHHO
HO
R RR R
R1 OH HO OH
OH
R1 R1 R1
R-CHO, Ethanol, HCl
                           
                                    1   R  =  CH3                      R1  =  CH3    
                           2   R  =  C6H13                   R1  =  CH3            
                           3   R  =  CH3                       R1  =  H
                           4   R  =  C6H13                   R1   =  H
                           5   R  =  C6H5                     R1  =  CH3 
                           6   R  =  C6H4Br                 R1  =  CH3 
                           7   R  =  C6H5                     R1   =  H
                           8   R  =  C6H4Br                 R1 =   H
 
Scheme 1. Condensation reaction between resorcinol and aldehyde 
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 The conformational analysis of the compound 1-8, revealed the existence of two 
distinct conformations.  Compounds 1-4 with alkyl groups (from the aliphatic aldehydes) 
on the lower rim preferred the crown conformation in solution, while compounds 5-8, 
with phenyl ring on the lower rim of the resorcinarene were observed in the chair 
conformation. Figure 3 and Figure 4 shown below are the 1H NMR spectra for 
compounds 1 and 6. The data is in agreement with the structures reported in literature 2. 
 
Figure 3. 1H NMR Spectrum of Compound 1 
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Figure 4. 1 H NMR Spectrum of Compound 6 
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2.1c. Bromination of Octahydroxy Resorcinarenes 
Bromination of resorcinarenes 1, 2 and 9 was successfully achieved in ethyl methyl 
ketone (2-butanone) with NBS at room temperature (Scheme 2). The reaction mixture 
was concentrated in vacuo, dissolved in methanol and was precipitated in ice cold water. 
 
HO OH
HO
HO
R RR R
H OH HO OH
OH
H H H HO OH
HO
HO
R RR R
Br OH HO OH
OH
Br Br Br
NBS, 2-Butanone
                           
                           1   R  = CH3                    10  R  = CH3    
                           2   R  = C6H13                 11  R  = C6H13            
                           9   R  = C9H19                 12  R  = C9H19  
 
Scheme 2. Bromination of Octahydroxy Resorcinarene  
1H NMR of brominated resorcinarenes 10-12 lacked the resonance for the C-2 aromatic 
proton at 6.3 ppm and in the 13C NMR the C-2 (brominated carbon) was shifted upfield 
from 130.0 ppm to 110.0 ppm. 
 
2.2 Allylation of Octahydroxy resorcinarenes 
2.2a Allylation of Octahydroxy resorcinarenes (1, 2, 10, 11, 12) 
 Resorcinarenes, 1, 2, 10, 11, 12 were perallylated by reaction with allyl bromide 
in presence of potassium carbonate in refluxing acetone (Scheme 3).  The solid residue 
was filtered off and the reaction mixture was concentrated in vacuo.  Compound 13-17 
were purified by recyrstallization from 7:3 mixture of acetone and methanol which 
yielded colorless crystals. Perallylation in compound 14 was confirmed from the signal's 
integral values in its 1H NMR spectrum.  Allylic proton (O-CH2) appeared at 4.1 ppm, the 
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vinylic proton (CH=CH2) appeared at 5.0-5.2 ppm and the non-terminal vinylic proton 
(CH=CH2) appeared at 5.9 ppm.  In the 13C NMR spectrum, the allylic carbon appeared 
at 65.0 ppm, the terminal vinylic carbon appeared at 117.0 ppm and the non-terminal 
carbon appeared at 134.0 ppm. 1H NMR of compound 13 had broad resonances, which 
made it difficult to assign individual resonances.  Its 13C NMR showed resonances for the 
allylic carbon at 74.0 ppm, the terminal vinylic carbon appeared at 116.3 ppm and the 
non-terminal carbon appeared at 134.7 ppm.  Perallylated compounds 15-17 were in 
accordance with compound 14.  Figure 5 and 6 shows the ORTEP plot of compound 13, 
and 17 which confirmed the existence of molecule in the boat conformation, with all 
methyl groups in axial position.  The crown conformation that existed in hydroxy 
resorcinarene no longer existed because of the absence of hydrogen bonding, a stabilizing 
force for the crown conformation.  
                   
Figure 5. Crystal Structure of Compound 13 
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O O
O
O
R RR R
R1 O O O
O
R1
R1 R1HO OH
HO
HO
R RR R
R1 OH HO OH
OH
R1 R1 R1
Allyl bromide, K2CO3, 
Acetone
Compound No R R1
13
14
15
16
17
CH3
C6H13
C6H13
C9H19
CH3
CH3
CH3
Br
Br
Br
% yield
76%
55%
68%
35%
48%  
Scheme 3. Allylation reaction of octahydroxy resorcinarene  
                                     
Figure 6: Ortep Plot Compound 17 
Figure 7 shown below is the crystal structure of compound 16, which was crystallized 
from mixture of acetone and methanol showing the nonyl group in axial position. 
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 Figure 7: Ortep plot of compound 16 
2.2b Allylation of Octahydroxy resorcinarenes (3, 4) 
 Allylation reaction was tried on compounds 3 and 4 following the 
established procedure, described earlier, but the desired product yield was low. So, 
reaction conditions were modified and optimized; Allylation was performed in a pressure 
vessel, which allowed reaction to be performed at higher temperature and pressure 
(Scheme 4).  Reactions in pressure vessel were performed at 1200C, and pure products 18 
and 19 were obtained upon column chromatography in 78% and 22% yield, respectively. 
Structures of compounds 18 and 19 were analyzed by 1H NMR and 13C NMR.  Mass 
spectral data (MALDI) on compound 19 [calculated m/z = 1144.77 (M+); observed m/z 
=1167.985 (M+Na+)] was in agreement with the structure. 
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O O
O
O
R RR R
R1 O O O
O
R1
R1 R1HO OH
HO
HO
R RR R
R1 OH HO OH
OH
R1 R1 R1
Allyl bromide, K2CO3, 
Acetone
Pressure vessel, 90-120oC
                           
                                    
                          
                           3   R  = CH3                     R1 = H
                           4   R  = C6H13                  R1 = H
                           
                                   
                           
                           18   R  = CH3                      R1 = H
                           19   R  = C6H13                   R1  = H  
  Scheme 4. Allylation reaction of octahydroxy resorcinarene 3, 4 
 
2.2c Allylation of Octahydroxy compounds 5-8  
 Resorcinarenes 5-8 were perallylated using acetone as a solvent and potassium carbonate 
as a base in 46-68% yield (Scheme 5).  It is important to point out that we also 
investigated a number of bases (NaH, KOtBu, etc.) in DMF but a complex mixture of 
products with low yield became a problem. Also, the removal of DMF by distillation was 
tedious and might have attributed to the decomposition or side reactions.  Compounds 20-
23 were analyzed by 1H- and 13C NMR and APCI MS data.  1H NMR spectrum clearly 
showed the changes occurred between 4.0 and 6.0 ppm after perallylation reaction.  
Allylic proton (O-CH2) appeared between 4.0-4.4 ppm, the vinylic proton (CH=CH2) 
appeared between 5.0-5.4 ppm and the non-terminal vinylic proton (CH=CH2) appeared 
between 5.8-6.0 ppm (Figure 8).  In the 13C NMR spectrum, the allylic carbon appeared 
between 65.0-75.0 ppm, the terminal vinylic carbon appeared between 115.0-120.0 ppm 
and the non-terminal carbon peak appeared between 125.0-130.0 ppm.  
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O O
O
O
R RR R
R1 O O O
O
R1
R1 R1HO OH
HO
HO
R RR R
R1 OH HO OH
OH
R1 R1 R1
Allyl bromide, K2CO3, 
Acetone
                           
                                    
                           5   R  = C6H5                    R1  = CH3
                           6   R  = C6H4Br                R1  = CH3
                           7   R  = C6H5                    R1 = H
                           8   R  = C6H4Br                R1  = H
                           
                                    
                     20   R  = C6H5                     R1  = CH3
                     21   R  = C6H4Br                 R1  = CH3
                           22   R  = C6H5                     R1  = H
                           23   R  = C6H4Br                 R1= H
Compound No DMF/KOtBu Acetone/K2CO3
20
21
22
23
48%
68%
46%
65%
54%
68%
57%
70%  
Scheme 5. Allylation reaction of octahydroxy resorcinarene 5-8 
 
 
  
 
Figure 8: 1H NMR spectrum of compound 21  
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Compound 21 was recyrstallized as light yellow colored crystals from acetone and 
methanol solvent (7:3) system.  The ORTEP plot of compound 21 (Figure 9), shows the 
resorcinarene ring in the preferred chair conformation with the allyloxy groups on upper 
rim and the two phenyl rings in axial position and other two in equatorial position . 
                
 
 
 
 
Figure 9. Crystal Structure of Compound 21 
2.3. Study of Ring closing metathesis on Resorcinarenes  
2.3a Introduction to Ring closing metathesis 
Intramolecular cyclizations leading to a bridged structure have been a very important to 
the synthesis of many cavitands.  Ring-closing metathesis (RCM) is becoming a preferred 
approach to synthesis of medium and large sized macrocyclic molecules.  Resorcinarenes 
have two well-defined rims; a lower rim defined by alkyl or phenyl substituents from 
corresponding aldehyde and an upper rim defined by hydroxyl groups of resorcinol.  The 
RCM reaction on perallylated resorcinarenes can be utilized to manipulate the cavity size.  
 
 15
In this chapter, I report the RCM reaction on resorcinarenes with small aliphatic chain, 
longer aliphatic chain, and aromatic rings. Also effect of the resorcinol's C-2 substituent 
on RCM was investigated.  Grubbs’ generation I catalyst, which has been widely used for 
ring closing metathesis due to its remarkable functional group tolerance, operational 
simplicity, high stability and commercial availability was utilized in this investigation. 
Interesting conformational dynamics in the octaallyloxy resorcinarene, due to its 
flexibility, (Figure 10) resulted in interesting observations summarized in the following 
sections. 
 
Figure 10. Grubb's generation I catalyst. 
2.3b Ring closing metathesis on compounds 13 and 18 
Resorcinarenes 13 and 18 were subjected to RCM to obtain compounds 24 and 25, 
respectively (Scheme 6). The reactions were carried out under nitrogen atmosphere in 
dry dichloromethane using 8 mol % of Grubb’s catalyst (Gen I).  The reaction was 
monitored for 4 days.  The desired product was separated by column chromatography in 
13-16% yield.  Starting material was recovered by column chromatography and was 
reused in subsequent reaction.  The characterization was done by mass spectral data and 
13C data.  In the 13C NMR spectrum of compound 24 [APCI MS m/z =893.5 (M+H+)], 
the terminal allylic carbon (C=CH2) resulted in two resonances at 117.0, 117.8 ppm; the 
O-CH2 carbon region had three peaks at 70.0, 73.0 74.0, ppm; the non terminal vinylic 
carbon was observed as three different resonances at 133.0, 133.7, 134.2 ppm.  A careful 
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analysis of the NMR data and its molecular weight suggested formation of the one 
bridged cavitand.  The multiplicities in the 13C NMR spectrum can be explained 
considering that the structure 24 has a plane of symmetry.  Mass spectral data (APCI MS) 
on compound 24 [calculated m/z = 892.49 (M+); observed m/z =893.5 (M+H+)] , 25 
[calculated m/z = 836.43 (M+); observed m/z =837.4 (M+H+)] was in agreement with the 
structure. 
 
O O
O
O
R RR R
R1 O O O O
R1 R1 R1
Grubb's catalyst, Dry DCM
R.T., 4 days
24 R1  = CH3             
25 R1  = H
13    R1 = CH3             
18    R1 = H
O O
O O
R RR R
R1
O O O O
R1 R1 R1
 
Scheme 6. Ring Closing Metathesis of Octaallyloxy Resorcinarene 24 and 25. 
 
2.3c. Ring Closing on compounds 20-23  
Compounds 20-23 were treated with Grubb’s catalyst (Gen I) under conditions described 
earlier, leading to formation resorcinarene 26-29 in 17-22% yield.  Several reactions were 
performed with increasing concentration of Grubbs catalyst (5-10 mole %), but without 
increased product yields.  Products were isolated by column chromatography using 6% 
ethyl acetate and hexane mixture as an eluent.  Scheme 7 shown below is the top view 
representation of the synthetic scheme. 
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26   R = Ph                          R' = H
27 R = Ph-Br                    R' = H  
               Scheme 7. Ring Closing Metathesis on Resorcinarenes with aryl substituents 
 1 H NMR data had overlapping, broad resonances and could not be used for confirmation 
of the structure.  Therefore, 13C NMR data was used because of its wider (0-200 ppm) 
and sharp carbon resonances.  Careful analysis of the products suggested a two bridged 
cavitand.  The two fold symmetry, indicated by the doubling of the carbon resonances 
upon bridge formation, suggested the two bridges were formed across form each other.  
MALDI Mass spectral measurements confirmed the structure as a two bridged structure; 
26 Mass spectral data (APCI MS ) on compound 26 [calculated m/z = 1056.00 (M+); 
observed m/z =1056.46 (M+)], 27, [calculated m/z = 1368.10 (M+); observed m/z 
=1385.00 (M++ H2O )] were in agreement with the structure of the respective compounds 
Unfortunately, the compound could not be crystallized for x-ray diffraction data 
collection. 
 Following a similar reaction procedure, compound 28 and 29 were synthesized 
via ring closing metathesis of their respective allyloxy precursors 11 and 12 (Scheme 8). 
A detail structural analysis of the products was undertaken.  The 1H and 13C NMR data 
suggested formation of a single bridged compound.   
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28   R = Ph                         R' = CH3              
29  R = Ph-Br              R' = CH3  
Scheme 8. Ring Closing Metathesis in case of methyl C-aryl Octaallyloxy            
Resorcinarene 
 
 MALDI Mass spectral data on compound 28 [calculated m/z = 1140.55 (M+); observed 
m/z =1163.48 (M+Na+)], 29 [calculated m/z = 1456.20 (M+); observed m/z =1479.54 
(M+Na+)] was in agreement with the structure.  Yields in both cases were around 10%.  
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Figure 11. DEPT 13C-NMR of  compound 29 
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2.3d Ring Closing Metathesis on Resorcinarenes 15 and 16  
The perallylated resorcinarenes 15 and 16 served as acyclic diene precursors for ring 
closing metathesis reaction. Compounds 15, 16 were treated with Grubb’s catalyst 
(Generation I) in dichloromethane (Scheme 9). Reaction was carried out at room 
temperature for 96 hrs which led to the observation of two spots having lower Rf value 
than starting substrate on thin layer chromatography.  The reaction mixture was subjected 
to column chromatography in 6% ethyl acetate and hexane.  The compound 30 and 31 
were isolated in 23% and 32%, respectively.  The absence of the terminal vinylic proton 
(-C=CH2) peak at 4.5 ppm in 1H NMR and at 117.0 ppm in 13C NMR spectra suggested 
formation of a bridged cavitands.  Figure 12 shown below is the comparative proton 
spectrum of compound 31 with its precursor molecule compound 16.  
O O
O
O
R RR R
Br
O O O O
Br
Br
Br
O O
O
O
R RR R
Br
O O O O
Br Br Br
Grubb's Catlyst-I
Dichloromethane, RT
5-8 mol%
15 R= C6H13               30 R= C6H13 
16 R= C9H19               31 R= C9H19  
Scheme 9. Synthesis of Four bridged Resorcinaranes 
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Figure 12. Comparative proton NMR spectrum of compound 31 and its precursor 
molecule compound 16 
 
 
2.4. Study of Inter/Intramolecular Ring Closing  
 
To understand ring closing metathesis and investigate the intra- or inter- molecular ring 
formation we subjected perallylated resorcinol to RCM reaction using Grubb’s catalyst. 
Reactions were tried with varying reaction concentration and mol % of catalyst.  The 
intra-molecular ring closing was never observed. 
 21
                            
OHHO
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R
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DCM
R
OO
 
Scheme 10. Study of Inter/Intra molecular ring closing 
Energy minimization calculation using MM2 MODEL on the resorcinarene 13, indicated 
that the intermolecular ring closed structure was about 6 Kcal less that the intermolecular 
ring closed structure.   
 
 
 
 
 
 22
Summary 
Below given is the table which summarizes the data.( Table 1) 
Compound No: R R1 Bridges formed 
24 CH3  CH3 one 
25 CH3 H one 
30 C6H13 Br four 
31 C9H19 Br four 
28 C6H5 CH3 one 
29 C6H4Br CH3 one 
26 C6H5 H two 
27 C6H4Br H two 
  
Table 1: Results of Ring closing metathesis 
Conclusion 
In conclusion to this study, I have investigated the effect of alkyl and aryl substituent on 
ring closing metathesis. It was observed that longer hydrophobic aliphatic chains favor 
ring closing metathesis. It was also observed formation of four bridged compound is 
more favored in compounds with crown conformation over chair conformation. From the 
studies described in this chapter bulky groups at C-2 position of resorcinol favor ring 
formation.  When smaller group such as hydrogen is present it does not favor ring 
formation due to steric effects.  
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CHAPTER 3 
 
LEWIS ACID CATALYZED SYNTHESIS OF RESORCINARENES FROM 2, 4-
DIMETHOXY CINNAMIC ACID AND STUDY OF RESROCINARENE'S 
ANTIMICROBIAL ACTIVITY  
 
3.1 Synthesis of resorcinarenes from 2, 4 dimethoxy cinnamic acid 
Bruno 20 et al first described the Lewis acid catalyzed synthesis of resorcinarene starting 
form 2,4- dimethoxycinnamic acid.  It involved esterification of 2, 4-dimethoxy cinnamic 
acid followed by treatment with BF3 etherate under carefully controlled conditions 
leading to the formation of tetramerized resorcinarenes.  Influence of Lewis acid, 
temperature, and reaction time and their effects on the resorcinarene conformation had 
also been described.  Interestingly, it was noted that longer reaction times always led to 
chair conformation.  Using the procedure described by Bruno et al., compound 33 was 
isolated after a reaction time of 10hrs.  This chapter discusses in detail the strategy I 
employed in preparation of resorcinarenes and their functionalization. 
3.2 Synthesis of resorcinarenes  
Another high yielding synthesis of resorcinarenes involves the lewis acid catalyzed 
tetramerization of 2, 4-dimethoxy cinnamates. The synthesis began with the base 
catalyzed esterification of our starting material 2, 4-dimethoxy cinnamic acid in acetone 
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with potassium carbonate and ethyl iodide. The reaction was refluxed for 12hrs and 
filtration of the solid provided us with quantitative yield of ethyl ester of dimethoxy 
cinnamic acid. Scheme 12 shown below is the esterification reaction.  The compound 
was characterized by 1H NMR; the ethyl ester resonances were observed at 1.34 ppm (t, 
J=7.25) for (CH2CH3), 4.24 ppm (q, J= 7.25) for (CH2CH3 ). 
 
OMeMeO
O
OH
OMeMeO
O
O
EtI, Acetone, K2CO3
Reflux 12 hrs
33  
Scheme 11: Esterification of Dimethoxy cinnamic acid 
The ester 33 was treated with BF3 etherate in chloroform at room temperature for 10 hrs, 
after which the reaction was quenched with methanol and concentrated in vacuo.  The 
product 34 was isolated by column chromatography in 6% methanol/dichloromethane 
mixture in 67% yield.  The compound was analyzed by NMR.  1H NMR- 1.03 ( d, J= 
9Hz ) for methyl protons, 2.87 (d, J= 7.75Hz) for ArCHCH2, 3.5ppm (s) for OCH3 
protons, 3.72 ( q, J=4.75Hz) for CH2CH3, 4.86 (s) for benzylic proton, 6.19 ( d, J= 
9.75hz), 6.54 (s ) for aromatic protons confirmed that compound exist in crown 
conformation with the ethyl groups all pointing in axial  position. The NMR data was in 
agreement with the data reported in the literature.20   
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OMeMeO
O
O
CH2COOEtEtOOCH2C
EtOOCH2C
CH2COOEt
OMe
OMe
OMeMeO
MeO
MeO
MeO OMe
BF3Et2O, CHCl3
RT, 10 hrs
3433  
Scheme 12: Formation of C-ethyl resorcinarene 34 
The compound 34 was subjected to demethylation using aluminum trichloride in 
dichloromethane (Scheme 14).  The reaction was performed at room temperature for 12 
hrs, diluted with dichloromethane and washed with 100ml of water, brine and was 
separated on a column with 44% yield.  The compound was analyzed by NMR which 
showed resonance for methoxy as well as hydroxyl protons indicating that the compound 
was partially demethylated to compound 35. 
CH2COOEtEtOOCH2C
EtOOCH2C
CH2COOEt
OMe
OMe
OMeMeO
MeO
MeO
MeO OMe
33
AlCl3, DCM, RT
CH2COOEtEtOOCH2C
EtOOCH2C
CH2COOEt
OH
OMe
OHHO
MeO
MeO
MeO OMe
35  
Scheme 13: Demethylation of compound 35 
 
 Compound 34 was subjected to reduction using lithium aluminium hydride in THF. The 
reaction was monitored by TLC. LAH was added to reaction mixture at 00c and reaction 
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mixture was allowed to warm up to room temperature. Reaction was carried out for 10 
hrs after which it was quenched by 0.5ml of water, 0.5ml of saturated sodium chloride 
solution and extracted into DCM in a seperatory funnel. It was concentrated in vacuum, 
dried and NMR of the product was taken, which indicated the conversion of ester to 
primary alcohol in 56% yield.  New resonance was found for hydroxyl groups at 2.0 ppm 
with absence of resonances for ethyl peaks.  Scheme 15 shown is the reduction reaction 
of ester to alcohol. 
CH2COOEtEtOOCH2C
EtOOCH2C
CH2COOEt
OMe
OMe
OMeMeO
MeO
MeO
MeO OMe
34
LAH, THF, RT
CH2CH2OHHOH2CH2C
HOH2CH2C
CH2CH2OH
OMe
OMe
OMeMeO
MeO
MeO
MeO OMe
36  
Scheme 15: Conversion of Ester to alcohol 
To the conclusion of this chapter, I have employed the easier route in the synthesis of 
resorcinarenes that cannot be synthesized by normal condensation method. 
 
3.3 Introduction to Study of Antimicrobial activity of Resorcinarenes 
 The pursuit of antimicrobially active compounds against a wide variety of 
microorganisms is an area of intense and important research. Antimicrobial activity of 
calixarenes was tested by Lamartine21 et al in 2002. In the present study, we examined 
the relative antimicrobial activity of resorcinarenes having different side chains, 
substitution groups against bacteria and yeasts. Antimicrobial activity against the various 
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species was evaluated by zone of inhibition to distinguish between the compounds for 
this desired property.21  Calixarenes can be modified for host molecules with defined 
structure and function. I have tested resorcinarenes against wide variety of bacteria 
includes ( P.aeruginosa, S. aureus, M.luteus, E.coli, B.subtilis) and yeasts( C.albicans). 
Not much research was carried out in this field, so we have choosen this area of interest 
to test the compounds for desired property. 
 
3.4. Testing of resorcinarenes for Antimicrobial activity 
I employed Kirby Bauer’s disk diffusion method which a standard method that has been 
used for years to test the compounds for antimicrobial activity and is initial stage to test 
the activity of compounds. The disk-diffusion method (Kirby-Bauer) is more suitable for 
routine testing in a clinical laboratory where a large number of isolates are tested for 
susceptibility to numerous antibiotics. An agar plate is uniformly inoculated with the test 
organism and a paper disk impregnated with a fixed concentration of an antibiotic is 
placed on the agar surface. Growth of the organism and diffusion of the antibiotic 
commence simultaneously resulting in a circular zone of inhibition in which the amount 
of antibiotic exceeds inhibitory concentrations. The diameter of the inhibition zone is a 
function of the amount of drug in the disk and susceptibility of the microorganism. 
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3.4a Preparation of Agar plates 
Below shown are the organisms that are employed for testing and nutrient media used for 
their growth. 
a) Bacillus subtilis 
b) Micrococcus luteus                       Nutrient medium                                                
c) Pseudomonas aeruginosa 
d) Candida albicans                           Saboraud Medium 
e) Escherichia coli   
                                                             Liquid broth 
f) Staphylococcus aureus                  
 
Preparation of Nutrient /Liquid /Saboraud medium 
11.5 g of nutrient agar/20gof LB/ 32.5g of Saboraud media that is available commercially 
were taken into clean 500mL deionized water, heated till the mixture was homogenous. It 
was autoclaved for 17 min at temperature of 1210C to sterilize the media .It was carefully 
removed from autoclave and cooled down to 500C and 20ml of this media was poured 
into Petri plates under aseptic conditions. The Petri plates were allowed to cool to room 
temperature and can be used as and when needed.  
Preparation of Broth for growth of Organisms 
The broth was prepared similarly to the above described procedure, broth media was used 
instead. 20ml aliquot of this solution was taken into test tubes and used when needed. 
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Preparation of Single colony of organism 
In order to test the activity of compound it was always advisable that single colony of the 
organism to be tested. The single colony of the organism was prepared by taking the 
organism culture and streaking the organism onto Petri plate containing the appropriate 
medium for growth. It was incubated for 2 days at 370C in incubator, when the growth 
was seen, a single colony from this Petri plate was transferred into broth medium under 
aseptic conditions and allowed to incubate for 2 days on a rotary shaker. This culture is 
good for 2 weeks if stored in the refrigerator. Below shown (Figure 13) is the schematic 
representation of above described procedure. 
Preparation of Discs 
Paper discs are available commercially. The compound to be tested (25mg) is taken into 
clean vial and diluted with miscible solvent to 1ml. 40µL of this solution contains 1mg of 
compound , 4ul contains 0.1mg and 0.4ul contains 0.01mg. The appropriate solution of 
this was transferred onto paper discs using microlitre pipettes and was dried carefully. 
Transfer of Discs onto Agar media  
The agar filled plates are warmed to 370C in incubator for 2 hrs before the transfer of 
discs. The organism was streaked onto agar plates and compound filled disc was carefully 
transferred onto Petri plate under aseptic conditions. It was incubated at ambient 
temperature for 1 day and zone of inhibition if seen was noted.  
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Nutrient medium
Incubate for  
1-2 days 
Autoclaving Preparation of 
Petri plates 
 
 
Streaking 
 Transfer of single colony 
into nutrient medium  
Shake it for one
day till you see 
turbidity  
 Spread small amount of above solution onto fresh 
 Petri plate and place the compound filled disc and 
incubate for nearly one day.
                                      Schematic representation 
Figure 13 : Schematic representation for preparation of Petri plates 
Results and Discussion 
I have tested 30 resorcinarenes for antimicrobial activity. The results are summarized in 
following tables. It was observed that- (1) resorcinarenes prepared from resorcinol had 
higher activity than those from methyl resorcinol, (2) the allylation of the phenolic 
hydroxyl resulted in decreased potency, (3) Presence of polar groups on the upper rim led 
to higher potency.  
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Structure of compound R R1 Zone of 
Inhibition 
Organism 
CH3 C6H13   
CH3 CH(CH2CH3)2   
CH3 CH3   
H CH3   
H C6H13   
H C9H19   
H CH(CH2CH3)2   12mm M.luteus 
H C6H5   
H C6H4Br   9mm M.luteus 
 
OH
OH
HO
OH
OH
HO
HO
HO
RR
R R1
R
R1 R1
R1  
H 
 
C6H4Cl   
 
Table 2: Antimicrobial activity of Hydroxy Resorcinarenes  
Structure of compound R R1 Zone of 
Inhibition 
Organism 
CH3 C9H19   
CH3 CH(CH2CH3)2   
CH3 CH3   
H C6H13 8mm P. aeruginosa 
M. luteus 
H C9H19   
H CH(CH2CH3)2   
H C6H5 8mm S. aureus 
H C6H4Br   
 
O
OO
O
OO
O
O
R1
R1
R1
R1
R
R R
R
 H 
 
C6H4Cl  
8mm 
P. aeruginosa 
M. luteus 
E.coli 
S.aureus 
 
Table 3: Antimicrobial activity of Perallylated Resorcinarenes 
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Structure of compound R R1 Zone of 
Inhibition 
Organism
CH2 Br C6H13   
CH2CH2 COOH C6H13 12mm 
10mm 
8mm 
M.luteus 
S.aureus 
E.coli 
CH2 (CHCOOEt)2 C6H13   
CHCH2 COOCH3 C6H13   
CH2 (CHCH2-OGlu)2 C6H13   
CH2 (CHCH2OH)2 C6H13   
CH3 C6H5   
 
O
O
O
O
O
O
O
O
R1R1
R1 R1
R
R1 R1
R1  
CH3 C6H4Br   
 
Table 4: Antimicrobial activity of Methylene Bridged Resorcinarenes 
 
Structure of compound R R1 Zone of 
Inhibition 
Organism 
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CH(CH2CH3)2
  
 
Table 5: Antimicrobial activity of bridged Resorcinarenes 
In conclusion to this study, we have observed antimicrobial activity on certain 
resorcinarenes which had hydrogen in C-2 position of resorcinol. Further extensive 
studies have to be carried out to figure the antimicrobial activity of resorcinarenes on 
wide variety of bacteria and fungi.  
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CHAPTER 4 
                                          EXPERIMENTAL SECTION 
4.1 General experimental procedure  
 
 All solvents and reagents were commercially available. Heptanal was purified by 
distillation. NMR spectra were recorded on 250 MHz, 400 MHz and 500 MHz 
spectrometers. Mass spectra were recorded in APCI mode and using MALDI. 
                 Synthesis of octahydroxy resorcinarene (1): -Methyl resorcinol (10g, 
0.081mol) was dissolved in (62.7mL, 775mL/mol) ethanol and (14.9mL, 185mL/mol) 
37% aqueous HCl. The solution was cooled in ice bath and (3.56mL, 0.081mol) 
acetaldehyde (which was maintained at 00C) was added to above solution slowly over a 
period of 30 min. Then the mixture was allowed to warm to room temperature. The 
reaction was refluxed for nearly 12 hrs. Then the reaction mixture was poured onto 
500mL of ice cold water. So obtained yellow colored precipitate was filtered through 
buchner funnel and the precipitate is washed several times until it turns neutral to pH 
paper. It is dried and NMR was taken in DMSO d6.  It was synthesized in 67% yield 
(8.4g). 1H NMR (DMSO) δ 1.75(d, 12H J= 7.5Hz ), 1.93(s, 12H), 4.4 (q, 4H J= 7.5Hz ), 
7.4 (s, 4H,), 8.7(s, 8H). 
Synthesis of  octahydroxy resorcinarene (2): - Methyl resorcinol (10g, 0.081mol) was 
dissolved in (62.7mL, 775mL/mol) ethanol and (15.1mL, 185mL/mol) 37% aqueous 
HCl. The solution was cooled in ice bath and (11.3mL, 0.081mol) heptaldehyde was 
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added to above solution slowly over a period of 30 min. Then the mixture was allowed to 
warm to room temperature. The reaction refluxed for nearly 12 hrs after which I observed 
yellow colored precipitate. So obtained precipitate was filtered through buchner funnel 
and the precipitate is washed several times until it turns neutral to pH paper. It is dried 
and NMR was taken in DMSO d6 (250MHz).  It was synthesized in 88 % (10.7g) yield. 
 1H NMR (DMSO) δ 0.84 (t, 12H, J = 6.25Hz )), 1.23(m, 32H), 1.93(s, 12H), 2.21(s, 8H), 
4.18 (t, 4H J = 7.75Hz )), 7.21 (s, 4H), 8.69(bs, 8H). 
Synthesis of octahydroxy resorcinarene (3): - Resorcinol (10g, 0.091mol) was dissolved 
in mixture of 35mL ethanol, 35mL of water and (16.8mL, 775mL/mol) 37% aqueous 
HCl. The solution was cooled in ice bath and acetaldehyde (4mL, 0.091mol) was added 
to above solution slowly over a period of 30 min. Then the mixture was allowed to warm 
to room temperature and allowed to stir at room temperature for nearly one day. Then the 
reaction mixture was poured into 500mL of ice cold water .So obtained light yellowed 
colored precipitate was filtered through buchner funnel and the precipitate is washed 
several times until it turns neutral to pH paper. It is dried and NMR was taken in DMSO 
d6. It was synthesized in 48% (4.23g) yield. 
1H NMR (DMSO) δ 1.29 (d, 12H, J = 7.0Hz)), 1.93(s, 3H), 4.4(q, 4H, J= 7.5Hz)), 7.4(s, 
4H), 8.7(s, 8H). 
Synthesis of octahydroxy resorcinarene (4): -Resorcinol (10g, 0.091mol) was dissolved 
in (71mL, 775mL/mol) ethanol and (16.8mL, 185mL/mol) 37% aqueous HCl. The 
solution was cooled in ice bath and (12.7mL, 0.091mol) heptaldehyde was added to 
above solution slowly over a period of 30 min. Then the mixture was allowed to warm to 
room temperature. The reaction was then maintained at temperature of 600C for nearly 36 
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hrs. Then the reaction mixture was poured onto 500mL of ice cold water .So obtained 
precipitate was filtered through buchner funnel and the precipitate is washed several 
times until it turns neutral to pH paper. It is dried and NMR was taken in DMSO d6. It 
was synthesized in 78% (8.4g) yield.  
1H NMR (DMSO) δ 0.82 (t, 12H), 1.21 (m, 32H) 2.07 (m, 8H), 4.23 (t, 4H), 6.13 (s, 4H), 
7.12 (s, 4H), 8.55 (s, 8H). 
Synthesis of  octahydroxy resorcinarene (5): - Methyl resorcinol (10g, 0.081mol) was 
dissolved in (62.7ml, 775mL/mol) anhydrous ethanol and (15.1mL, 185mL/mol) 37% 
aqueous HCl.The solution was cooled in ice bath and (7.6mL, 0.081mol) benzaldehyde 
was added to above solution slowly over a period of 30 min. Then the mixture was 
allowed to warm to room temperature. The reaction was then maintained at temperature 
of 800C for nearly 12 hrs, forms yellow colored precipitate .So obtained precipitate was 
filtered through buchner funnel and the precipitate is washed several times until it turns 
neutral to pH paper. It is dried and NMR was taken in DMSO d6 (250Hz). It was obtained 
in 88% (8.4g) yield.  
1H NMR (DMSO) δ 1.9 (d, 12H), 5.25 (s, 2H), 5.6(s, 4H), 6.1 (s, 2H), 6.6 (d, 8H), 7.1 (d, 
12H), 7.6 (d, 8H). 
Synthesis of octahydroxy resorcinarene (6): - Methyl resorcinol (10g, 0.081mol) was 
dissolved in (62.7mL, 775mL/mol) ethanol and (15.1mL, 185mL/mol) 37% aqueous 
HCl.The solution was cooled in ice bath and (14.4g, 0.081mol) bromobenzaldehyde was 
added to above solution slowly over a period of 30 min. Then the mixture was allowed to 
warm to room temperature. The reaction was then maintained at temperature of 800C for 
nearly 12 hrs after which I observe formation of yellow colored precipitate .So obtained 
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precipitate was filtered through buchner funnel and the precipitate is washed several 
times until it turns neutral to pH paper. It is dried and NMR was taken in DMSO d6 
(250Hz).Compound 6 was synthesized in 90 % ( 8.8g) yield. 
 1H NMR (DMSO) δ 1.9 (d, 12H), 5.25 (s, 2H), 5.6 (s, 4H), 6.1 (s, 2H,), 6.6 (d, 8H), 7.1 
(d, 8H), 7.6 (d, 8H). 
Synthesis of octahydroxy resorcinarene (7): - Resorcinol (10g, 0.091mol) was dissolved 
in (71mL, 775mL/mol) ethanol and (16.8mL, 185ml/mol) 37% aqueous HCl. The 
solution was cooled in ice bath and (8.8mL, 0.091mL/mol) benzaldehyde was added to 
above solution slowly over a period of 30 min using syringe. Then the mixture was 
allowed to warm to room temperature. The reaction was then maintained at temperature 
of 800C for nearly 12 hrs after which we can see yellow colored precipitate. So obtained 
precipitate was filtered through Buchner funnel and the precipitate is washed several 
times until it turns neutral to pH paper. It was synthesized in 56% (5.34g) yield. NMR 
was taken in DMSO.  
 1H NMR (DMSO) δ 5.65 (s, 4H), 6.17 (s, 4H), 6.32 (bs, 4H), 6.72-6.8 (m, 8H), 6.92-
7.02 (m, 12H), 8.88 (d, 8H). 
Synthesis of octahydroxy resorcinarene (8): - Resorcinol (10g, 0.091mol) was dissolved 
in (71mL, 775mL/mol) ethanol and (16.8mL, 185mL/mol) 37% aqueous HCl. The 
solution was cooled in ice bath and (16g, 0.091mol) bromobenzaldehyde was added to 
above solution slowly over a period of 30 min using syringe. Then the mixture was 
allowed to warm to room temperature. The reaction was then maintained at temperature 
of 800C for nearly 12 hrs after which we can see yellow colored precipitate. So obtained 
precipitate was filtered through buchner funnel and the precipitate is washed several 
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times until it turns neutral to pH paper. It is dried and NMR was taken in DMSO. It was 
synthesized in 67% (6.3g) yield. 
 1H NMR (DMSO) δ 5.32 (s, 2H), 5.48 (d, 2H), 6.14 (s, 2H), 6.2 (d, 2H), 6.58 (d, 8H), 
6.62 (d, 0.5H), 6.94 (d, 8H), 7.02 (d, 2H), 8.7 (d, 8H). 
Synthesis of Octahydroxy Resorcinarene (10):- 1g of Octahydroxy resorcinarene 1 was 
taken in 2- butanone (10mL/mmol) into round bottomed flask, stirred for 10 min.  6 eq of 
N-bromo succinimide was added to the above stirred solution in small amounts and 
reaction was stirred at room temperature for 12 hours. Reaction was monitored by thin 
layer chromatography. 2- Butanone was evaporated on Rota vapor which resulted in 
yellow color precipitate which was filtered and washed with cold 2- butanone.  
NMR was taken in DMSO. 1.42 (d,12H), 4.62 (d,4H), 6.82 (s,4H), 8.38 (s,8H). 
Synthesis of Octahydroxy Resorcinarene (11):- 1g of Octahydroxy resorcinarene 2 was 
taken in 2- butanone (10mL/mmol) into round bottomed flask, stirred for 10 min.  6 eq of 
N-bromo succinimide was added to the above stirred solution in small amounts and 
reaction was stirred at room temperature for 12 hours. Reaction was monitored by thin 
layer chromatography. 2- Butanone was evaporated on Rota vapor which resulted in 
yellow color precipitate which was filtered and washed with cold 2- butanone.  
NMR was taken in DMSO. 0.84 (s, 12H), 1.24 (s, 32H) , 2.2 (s,8H),  4.35 (t,4H), 7.35 
(s,4H), 9.1 (s,8H). 
Synthesis of Octahydroxy Resorcinarene (12):- 1g of Octahydroxy resorcinarene in 2- 
butanone (10mL/mmol) was taken into round bottomed flask, stirred for 10 min.  6 eq of 
N-bromo succinimide was added to the above stirred solution in small amounts and 
reaction was stirred at room temperature for 12 hours. Reaction was monitored by thin 
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layer chromatography. 2- Butanone was evaporated on Rota vapor which resulted in 
yellow color precipitate which was filtered and washed with cold 2- butanone.  
NMR was taken in DMSO. 0.84 (s, 12H), 1.24 (s, 54H), 2.2 (s,8H),  4.35 (t,4H), 7.35 
(s,4H), 9.1 (s,8H). 
Synthesis of octaallyloxy resorcinarene (13): -1g of Octahydroxy compound 1 was taken 
into round-bottomed flask and (20mL/mol) acetone was added to RBF. The reaction 
mixture was stirred till homogenous mixture was formed. Then (30eq) potassium 
carbonate was slowly added over a period of half an hour where the reaction mixture is 
ice cooled. Here we observe the change in color from brown to purple. Then the reaction 
mixture was brought to room temperature and (30eq) allyl bromide was added. The 
reaction mixture was heated to temperature of 600C for nearly 24-48 hrs. The reaction 
mixture was filtered and then concentrated and was recrystallized using 70% acetone 
methanol mixture. It was synthesized in 76% (1.2g) yield. Dept 135 was taken on this 
compound since the proton NMR of this compound gave broad peaks. Peaks at following 
ppm values were observed. δ (in ppm ) 10.54, 20.96, 32.79, 73.25, 116.12, 123.67, 
134.49. 
Synthesis of octaallyloxy resorcinarene (14): -1g of Octahydroxy compound 2 was taken 
into round-bottomed flask and (20mL/mol) acetone was added to RBF. The reaction 
mixture was stirred till homogenous mixture was formed. Then (30eq) potassium 
carbonate was slowly added over a period of half an hour where the reaction mixture is 
ice cooled. Here we observe the change in color from brown to purple. Then the reaction 
mixture was brought to room temperature and (30eq) allyl bromide was added. The 
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reaction mixture was heated to temperature of 600C for nearly 24-48 hrs. It was 
synthesized in 55% yield (0.7g). 
1H NMR (CDCl3) δ 0.8 (t, 12H), 1.2 (m, 56H), 1.85 (m, 8H), 2.15 (s, 12H), 4.25 (dd, 
16H), 4.55 (t, 4H), 5.2 (dd, 16H) 6.1 (m, 8H), 6.55 (s, 4H);  
13C NMR δ 10.6, 14.2, 22.8, 28.6, 29.5, 30.2, 32.1, 34.1, 35.4, 36.5, 40.0, 73.3, 116.2, 
124.0, 133.9, 153.6. 
Synthesis of octaallyloxy resorcinarene (15): -1g of Octahydroxy bromo compound 11 
was taken into round-bottomed flask and (20mL/mol) acetone was added to RBF. The 
reaction mixture was stirred till homogenous mixture was formed. Then (30eq) potassium 
carbonate was slowly added over a period of half an hour where the reaction mixture is 
ice cooled. Here we observe the change in color from brown to purple. Then the reaction 
mixture was brought to room temperature and (30eq) allyl bromide was added. The 
reaction mixture was heated to temperature of 600C for nearly 24-48 hrs. The reaction 
mixture was filtered and then concentrated and was recyrstallized using 70% acetone 
methanol mixture. NMR was taken in CDCl3. 0.77 (t, 12H), 1.16 (d, 32H), 1.48 (t,8H), 
1.82 (s,4H), 4.36 (t,16H), 5.14 (d,16H), 5.92 (s,8H). 
13C : 14.3, 22.8, 22.9, 28.8, 29.8, 32, 32.1, 35.0, 39.4, 74.1, 110.0, 117.4, 126, 133.9, 154. 
Synthesis of octaallyloxy resorcinarene (16): -1g of Octahydroxy bromo compound 12 
was taken into round-bottomed flask and (20mL/mol) acetone was added to RBF. The 
reaction mixture was stirred till homogenous mixture was formed. Then (30eq) potassium 
carbonate was slowly added over a period of half an hour where the reaction mixture is 
ice cooled. Here we observe the change in color from brown to purple. Then the reaction 
mixture was brought to room temperature and (30eq) allyl bromide was added. The 
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reaction mixture was heated to temperature of 600C for nearly 24-48 hrs. The reaction 
mixture was filtered and then concentrated and was recrystallized using 70% acetone 
methanol mixture. NMR was taken in CDCl3. 0.86 (t, 12H), 1.22 (d, 56H), 1.9 (s, 8H), 
4.45 (t, 20H), 5.23 (d, 16H), 6.01 (s, 8H), 6.96 (s, 4H). 
13C ( in ppm ) 14.3, 22.9, 28.8, 29.6, 29.9, 30.1, 32.2, 35.0, 39.4, 74.08, 110.0, 113.9, 
117.3, 126.1, 133.9, 138.6, 157.1. 
Synthesis of octaallyloxy resorcinarene (17): -1g of Octahydroxy bromo compound 10 
was taken into round-bottomed flask and (20mL/mol) acetone was added to RBF. The 
reaction mixture was stirred till homogenous mixture was formed. Then (30eq) potassium 
carbonate was slowly added over a period of half an hour where the reaction mixture is 
ice cooled. Here we observe the change in color from brown to purple. Then the reaction 
mixture was brought to room temperature and (30eq) allyl bromide was added. The 
reaction mixture was heated to temperature of 600C for nearly 24-48 hrs. The reaction 
mixture was filtered and then concentrated and was recyrstallized using 70% acetone 
methanol mixture. NMR was taken in CDCl3. 1.45 (t, 12H), 3.5 (s, 4H), 4.2 (s, 14H), 4.57 
(m, 16H), 5.04 (dd, 8H), 5.7 (s, 4H). 
13C ( in ppm ) 20.9, 33.9, 74.2, 117.1, 117.6, 125.2, 133.9, 134.1, 138.7, 152.8, 153.9. 
Synthesis of octaallyloxy resorcinarene (18): -1g of Octahydroxy compound 3 was taken 
into round-bottomed flask and (20mL/mol) acetone was added to RBF. The reaction 
mixture was stirred till homogenous mixture was formed. Then (30eq) potassium 
carbonate was slowly added over a period of half an hour where the reaction mixture is 
ice cooled. Here we observe the change in color from brown to purple. Then the reaction 
mixture was brought to room temperature and (30eq) allyl bromide was added. The 
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reaction mixture was heated to temperature of 600C for nearly 24-48 hrs. 13C NMR was 
taken in CDCl3. δ ( in ppm ) 20.96, 32.79, 73.25, 116.12, 123.67, 134.49. 
Synthesis of octaallyloxy resorcinarene (19): -1g of Octahydroxy compound 4 was taken 
into round-bottomed flask and (20mL/mol) acetone was added to RBF. The reaction 
mixture was stirred till homogenous mixture was formed. Then (30eq) potassium 
carbonate was slowly added over a period of half an hour where the reaction mixture is 
ice cooled. Here we observe the change in color from brown to purple. Then the reaction 
mixture was brought to room temperature and (30eq) allyl bromide was added. The 
reaction mixture was heated to temperature of 600C for nearly 24-48 hrs. 1H NMR 
(CDCl3) δ ( in ppm ) 0.65 (t, 24H), 1.2 (m, 16H), 1.4 (m, 4H), 4.2 (d, 16H), 4.3 (t, 4H), 
5.2 (dd, 16H), 5.9 (m, 8H), 6.2 (s, 4H), 6.9 (s, 4H). 
Synthesis of octaallyloxy resorcinarene (20): - 1g of Octahydroxy compound 5 was 
taken into round bottomed flask and (20mL/mol) DMF was added to RBF. The reaction 
mixture was stirred till homogenous mixture was formed .Then (16eq) potassium tertiary 
butoxide was slowly added over a period of one hour where the reaction mixture is ice 
cooled. Here we observe the change in color from brown to purple. Then the reaction 
mixture was brought to room temperature and (16eq) allyl bromide was added. The 
reaction mixture is heated to temperature of 700C for nearly 12 hrs. After the reaction is 
complete the reaction mixture is filtered from potassium tertiary butoxide and DMF was 
distilled over reduced pressure. Dichloromethane was added and reaction was washed 
with water, then with brine and then concentrated and compound was recrystallized in 
70% mixture of ethyl acetate and hexane. NMR of compound was taken in CDCl3 . 
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δ ( in ppm ) 2.12 (d, J=9.2Hz, 6H), 2.25 (d, J=9.2Hz, 6H), 3.64 (m, 16H), 5.05-5.20(m, 
16H), 5.60 (d, 2H, J=9.6Hz), 6.31 (d, 2H, J=9.6Hz), 5.85 (m, 8H), 5.93 (d, 4H), 6.60 (d, 
8H, J= 7.6Hz), 6.84 (d, 8H, J= 7.6Hz), 6.86 (s, 4H).  
Synthesis of octaallyloxy resorcinarene (21): - 1g of Octahydroxy compound 6 was 
taken into round bottomed flask and (20mL/mol) DMF was added to RBF. The reaction 
mixture was stirred till homogenous mixture was formed .Then (16eq) potassium tertiary 
butoxide was slowly added over a period of one hour where the reaction mixture is ice 
cooled. Here we observe the change in color from brown to purple. Then the reaction 
mixture was brought to room temperature and (16eq) allyl bromide was added. The 
reaction mixture is heated to temperature of 700C for nearly 12 hrs. After the reaction is 
complete the reaction mixture is filtered from potassium tertiary butoxide and DMF was 
distilled over reduced pressure. Dichloromethane was added and reaction was washed 
with water, then with brine and then concentrated and compound was recyrstallized in 
70% mixture of ethyl acetate and hexane. NMR of compound was taken in CDCl3. δ 2.12 
(d, J=9.2Hz, 6H), 2.25 (d, J=9.2Hz, 6H), 3.64-4.42 (m, 16H), 5.05-5.20 (m, 16H), 5.60 
(d, 2H, J=9.6Hz), 6.31 (d, 2H, J=9.6Hz), 5.85 (m, 8H), 5.93 (d, 4H), 6.60 (d, 8H, J= 
7.6Hz), 6.84 (d, 4H, J= 7.6Hz), 6.86 (s, 4H).  
Synthesis of octaallyloxy resorcinarene (22): - 1g of Octahydroxy compound 7 was 
taken into round bottomed flask and (20mL/mol) DMF was added to RBF. The reaction 
mixture was stirred till homogenous mixture was formed .Then (16eq) potassium tertiary 
butoxide was slowly added over a period of one hour where the reaction mixture is ice 
cooled. Here we observe the change in color from brown to purple. Then the reaction 
mixture was brought to room temperature and (16eq) allyl bromide was added. The 
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reaction mixture is heated to temperature of 700C for nearly 12 hrs. After the reaction is 
complete the reaction mixture is filtered from potassium tertiary butoxide and DMF was 
distilled over reduced pressure. Dichloromethane was added and reaction was washed 
with water, then with brine and then concentrated and compound was recyrstallized in 
70% mixture of ethyl acetate and hexane. NMR of compound was taken in CDCl3. 
Synthesis of octaallyloxy resorcinarene (23): - 1g of Octahydroxy compound 8 was 
taken into round bottomed flask and (20mL/mol) DMF was added to RBF. The reaction 
mixture was stirred till homogenous mixture was formed .Then (16eq) potassium tertiary 
butoxide was slowly added over a period of one hour where the reaction mixture is ice 
cooled. Here we observe the change in color from brown to purple. Then the reaction 
mixture was brought to room temperature and (16eq) allyl bromide was added. The 
reaction mixture is heated to temperature of 700C for nearly 12 hrs. After the reaction is 
complete the reaction mixture is filtered from potassium tertiary butoxide and DMF was 
distilled over reduced pressure. Dichloromethane was added and reaction was washed 
with water, then with brine and then concentrated and compound was recyrstallized in 
70% mixture of ethyl acetate and hexane. NMR of compound was taken in CDCl3. 
Synthesis of bridged resorcinarene (24): - To a stirred solution of octa-allyloxy  methyl 
resorcinarene (13) (1gm, .877 mmole) in dry methylene chloride (90mL) was added 
Grubb’s catalyst (5 mole%, 0.034gm, 0.042 mmole) in dry methylene chloride (25mL) at 
room temperature. Reaction was continued for 4days. Reaction mixture was then 
concentrated using a rotary evaporator and compound was obtained by column 
chromatography. 
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Synthesis of bridged resorcinarene (25): - To a stirred solution of octa-allyloxy  methyl 
resorcinarene (18) (1gm, .877 mmole) in dry methylene chloride (90mL) was added 
Grubb’s catalyst (5 mole%, 0.034gm, 0.042 mmole) in dry methylene chloride (25mL) at 
room temperature. Reaction was continued for 4days. Reaction mixture was then 
concentrated over rotary evaporator and was separated by column. 
Synthesis of bridged-resorcinarene (26): - To a stirred solution of octa-allyloxy-phenyl-
resorcinarene (22) (1gm, 0.89 mmole) in dry methylene chloride (93mL) was added 
grubb’s catalyst (8 mole%, 0.058gm, 0.071 mmole) in dry methylene chloride (20mL) at 
room temperature. Reaction was continued for 4days. Reaction mixture was then 
concentrated over rotavapor and column chromatography was run using 10% ethyl 
acetate and 90% hexane solvent system to separate two spots. Second spot (fraction) 
showed that four allyl groups are closed forming two bridges. It was confirmed by 13C, 
DEPT, Mass spectroscopy. DEPT (CDCl3) δ in ppm 41.8, 63.8, 68.6, 96.2, 98.99, 115.3, 
124.3, 126.6, 126.8, 127.3, 127.9, 128.1, 132.1, 132.7; MALDI m/z 1057.785 (M+ + H), 
1079.814 (M+ + Na).  
 Synthesis of bridged-resorcinarene (27): - To a stirred solution of octa-allyloxy-
bromophenyl-resorcinarene (23) (1gm, 0.89 mmole) in dry methylene chloride (93mL) 
was added grubb’s catalyst (8 mole%, 0.058gm, 0.071 mmole) in dry methylene chloride 
(20mL) at room temperature. Reaction was continued for 4days. Reaction mixture was 
then concentrated over rotavapor and column chromatography was run using 10% ethyl 
acetate and 90% hexane solvent system to separate two spots. Second spot (fraction) 
showed that four allyl groups are closed forming two bridges. It was confirmed by 13C, 
DEPT, Mass spectroscopy. DEPT (CDCl3) δ in ppm 41.8, 63.8, 68.6, 96.2, 98.99, 115.3, 
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124.3, 126.6, 126.8, 127.3, 127.9, 128.1, 132.1, 132.7; MALDI m/z 1057.785 (M+ + H), 
1079.814 (M+ + Na). 
 Synthesis of  bridged-resorcinarene (28): - To a stirred solution of octa-allyloxy- 
phenyl-methylresorcinarene (20) (1gm, 0.82 mmole) in dry methylene chloride (86mL) 
was added grubb’s catalyst (8 mole%, 0.054gm, 0.066 mmole) in dry methylene chloride 
(19mL) at room temperature. Reaction was continued for 4days. Reaction mixture was 
then concentrated over rotavapor and column chromatography was run using 10% ethyl 
acetate and 90% hexane solvent system to separate two spots. Second spot (fraction) 
showed that two allyl groups are closed forming one bridge. It was confirmed by 13C, 
DEPT, Mass spectroscopy. 13C NMR (CDCl3) δ in ppm (10.8, 10.9, 11.1, 11.3), 24.9, 
36.8, (44.2, 44.7, 44.9, 45.0), (68.6, 71.0, 73.9, 74.2), (116.4, 116.6, 116.6, 116.8, 117.0, 
117.3), (123.8, 124.1, 125.3, 125.8, 125.9, 126.3, 127.4, 127.4, 127.8, 127.8, 128.3, 
129.0, 129.2, 130.1, 131.2, 132.2, 132.4, 132.5, 132.7, 132.82, 132.8, 133.1, 133.2), 
(134.1, 134.1, 134.2, 134.2, 134.3, 134.3, 134.4), (141.4, 143.4, 143.6, 144.0), (154.1, 
154.3, 154.8, 154.9, 155.0, 155.0, 155.1, 155.6). 
 Synthesis of bridged-resorcinarene (29): - To a stirred solution of octa-allyloxy- 
bromophenyl-methylresorcinarene (21) (1gm, 0.67 mmole) in dry methylene chloride 
(70mL) was added grubb’s catalyst (8 mole%, 0.044gm, 0.054 mmole) in dry methylene 
chloride (15mL) at room temperature. Reaction was continued for 4days. Reaction 
mixture was then concentrated over rotavapor and column chromatography was run using 
10% ethyl acetate and 90% hexane solvent system to separate two spots. Second spot 
(fraction) showed that two allyl groups are closed forming one bridge. It was confirmed 
by 13C, DEPT, Mass spectroscopy. 13C NMR (CDCl3) δ in ppm 10.9, 11.0, 11.2, 11.3, 
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14.4, 29.9, 43.7, 44.1, 44.3, 44.5, 69.2, 73.8, 74.2, 74.5, 110.0, 116.6, 116.8, 116.9, 117.3, 
117.5, 117.8, 120.0, 120.1, 120.1, 124.3, 124.7, 125.8, 126.4, 126.8, 128.2, 129.7, 130.6, 
130.7, 130.8, 130.9, 130.9, 131.0, 132.3, 132.4, 132.5, 132.6, 133.8, 134.0, 134.1, 134.2, 
140.5, 142.6, 142.9, 143.6, 154.3, 154.8, 155.0, 155.2, 155.3, 155.4, 155.9. 
Synthesis of bridged resorcinarene (30): - To a stirred solution of octa-allyloxy bromo 
heptyl resorcinarene (15) (1gm, .684 mmole) in dry methylene chloride (72mL) was 
added Grubb’s catalyst (5 mole%, 0.028gm, 0.034 mmole) in dry methylene chloride 
(25mL) at room temperature. Reaction was continued for 4days. Reaction mixture was 
then concentrated over Rota vapor and was precipitated from mixture of acetone and 
dichloromethane. .   
1H NMR 0.86 (t, 12H), 1.23 (d, 56H), 1.9 (s, 8H), 4.82 (t, 20H), 5.95 (s, 8H), 6.96 (s, 
4H). 
 13C NMR 14.3, 22.9, 27.8, 29.6, 29.8, 29.9, 32.2, 36.6, 37.7, 77.5, 109.9, 113.6, 125.3, 
130.1, 135.3, 154.2. 
Synthesis of bridged resorcinarene (31): - To a stirred solution of octa-allyloxy bromo 
decyl resorcinarene (16) (1gm, .614 mmole) in dry methylene chloride (65mL) was added 
Grubb’s catalyst [8 mole%, 0.025gm, 0.031 mmole] in dry methylene chloride (25mL) at 
room temperature. Reaction was continued for 4days. Reaction mixture was then 
concentrated over Rota vapor and was recrystallised from mixture of ethyl acetate and 
hexane. 1H NMR ( CDCl3 ) 0.86 (t, 12H), 1.22 (d, 56H), 1.9 (s, 8H), 4.8 (d, 12H), 6.01 (s, 
8H), 6.96 (s, 4H). 
 13C NMR 14.3, 22.9, 28.8, 29.6, 29.9, 30.1, 32.2, 35.0, 39.4, 74.08, 110.0, 113.9, 126.1, 
133.9, 138.6, 157.1. 
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Synthesis of bridged resorcinarene (32): - To a stirred solution of octa-allyloxy bromo 
methyl resorcinarene (17) (1gm, .877 mmole) in dry methylene chloride (90mL) was 
added Grubb’s catalyst (5 mole%, 0.034gm, 0.042 mmole) in dry methylene chloride 
(25mL) at room temperature. Reaction was continued for 4days. Reaction mixture was 
then concentrated over Rota vapor and was precipitated from mixture of acetone and 
dichloromethane.  NMR was taken in CDCl3.( ppm ) 20.9, 33.9, 74.3, 117.1, 117.3, 
125.0, 134.1, 139.5, 153.9. 
Synthesis of Ethyl ester of 2,4 dimethoxy Cinnamic acid (33):- 0.3g of 2,4 dimethoxy 
cinnamic acid was taken into RBF and 14ml of acetone(10mL/mmol) was added and 
stirred still homogenous solution was obtained. To this solution 1g (5eg) of potassium 
carbonate was added in portion wise and 0.3mL (2eq) of ethyl iodide was added and the 
reaction was refluxed for 12 hrs. It was allowed to cool and base was filtered off, 
concentrated in vacuum, and so obtained product was taken for NMR. 
1H NMR revealed the existence of compound. Following peaks were found in CDCl3  
   1.30 (t, J=7.25) 3.83 (d, J=7.5) 4.23 (q, J= 7) 6.40 (s), 6.45 (m), 6.48 (m), 7.42 (d ,J= 
8.75) 7.94 ( d, J= 16.25). 
Synthesis of C-Ethyl Dimethoxy resorcinarene (34):-1g of compound 33 was taken into 
RBF and 6.5mL of chloroform (5mL/mmol) was added to the compound and allowed to 
stir for 5 min. 0.26mL of BF3 etherate (0.2mL/mmol) was added to the reaction mixture 
and the continued for 10hrs.The reaction was monitored by TLC and after 10hrs the 
reaction was quenched with methanol and so obtained precipitate was filtered off and it 
was concentrated in vacuum. The reaction mixture was purified by column 
chromatography (5% methanol and dichloromethane) and NMR was taken in CDCl3  
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 1.01 ( d, J= 9Hz), 1.13 ( m), 2.87 (d, J= 7.75Hz), 3.72 ( q, J=4.75Hz), 4.86(s), 6.19 ( d, 
J= 9.75Hz), 6.54(s). 
Synthesis of demethylated Resorcinarene (35):- 1g of compound 34 was taken into RBF 
and 40mL of dichloromethane was added to the reaction mixture. The reaction mixture 
was cooled in ice bath for 15 min and 2.8g of aluminium trichloride (20eq) was added in 
portion wise and reaction was allowed to continue for 12 hrs. The reaction was monitored 
by TLC. The reaction mixture was quenched with water and extracted into 
Dichloromethane and concentrated in vacuum. The major lower Rf spot was separated by 
column chromatography and NMR was taken in DMSO d6. 1.01 (d, J= 9Hz), 1.13 ( m), 
2.87 (d, J= 7.75Hz), 3.72 (q, J=4.75Hz), 4.86 (s), 6.19 ( d, J= 9.75hz), 6.54 (s) 8.8 (m). 
Synthesis of Hydroxy ethyl Resorcinarene (36):- 0.5g of compound 34 was taken into 
RBF and 16mL of tetrahydrofuran was added to the reaction mixture. The reaction 
mixture was cooled in ice bath for 15 min and 80mg of Lithium aluminium hydride (4 eq) 
was added in portion wise and reaction was allowed to continue for 12 hrs. The reaction 
was monitored by TLC and quenched with 0.5mL of water followed by 0.5 mL of 
saturated sodium chloride solution and extracted into ethyl acetate.  It was concentrated 
in vacuum. The major lower Rf spot was separated by column chromatography and NMR 
was taken in CDCl3. 1.13 ( m), 2.01 (s) 2.87 (d, J= 7.75Hz), 4.86 (s), 6.19 ( d, J= 9.75hz), 
6.54 (s). 
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4.2 Crystal data of Resorcinarenes 
(1) Crystal data of allyloxy-resorcinarene (13): - 
  Colorless parallelepiped, C60H72O8, F.W= 921.18, triclinic, space group P1, a= 
12.066(10), b= 15.927(12), c= 20.122(15) A0, β= 84.594(16)0, V= 3368(5) A0 3, Z= 2, 
Dα = 1.129 Mg m-3, T= 115 K. Data were collected on Kappa CCD diffractometer (2.50 
< θ < 29.50) using Mo Kα radiation, (λ= 0.71073A0 ). From the 80902 reflections 
measured, 11348 (I > 2σ (I)) were used in the refinements. 
(2) Crystal data of allyloxy-resorcinarene (15): - 
Colorless fragment, C56H56O8Br4, F.W.= 1176.65, orthorhombic, space group P2, a= 
8.826(17), b= 19.85(4), c= 29.78(4) A0, β= 900, V= 5217.6(17) A0 3, Z= 4, Dα = 1.185 
Mg m-3, T= 110 K. Data were collected on Kappa CCD diffractometer (2.50 < θ < 29.50) 
using Mo Kα radiation, (λ= 0.71073A0 ). From the 9131 reflections measured, 6563 (I > 
2σ (I)) were used in the refinements. 
(3) Crystal data of allyloxy-resorcinarene (16): - 
Colorless fragment, C88H124O8Br4, F.W.= 1629.51, monoclinic, space group P2(1), a= 
27.061(3), b= 18.98(18), c= 16.289(13) A0, β= 90.746(2)0, V= 8366.2(13) A0 3, Z= 4, Dα 
= 1.294 Mg m-3, T= 100 K. Data were collected on Kappa CCD diffractometer (2.50 < θ < 
29.50) using Mo Kα radiation, (λ= 0.71073A0 ). From the 40537 reflections measured,  (I 
> 2σ (I)) were used in the refinements. 
(4)  Crystal data of allyloxy-resorcinarene (21): -  
Colorless fragment, C80H80O8Br4, F.W= 1529.44, triclinic, space group P1, a= 12.36(2), 
b= 13.691(3), c= 19.796(4) A0, 92.301(11)0, V= 3189(11) A0 3, Z= 2, Dα = 1.218 Mg m-
3, T= 110 K. Data were collected on Kappa CCD diffractometer (2.50 < θ < 29.50) using 
 50
Mo Kα radiation, (λ= 0.71073A0 ). From the 9131 reflections measured, 6984 (I > 2σ (I)) 
were used in the refinements. 
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Figure 14. 1H NMR of compound 1 
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Figure 15. 13C  NMR of compound 1. 
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Figure 16. 1H NMR of compound 2 
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Figure 17. 13C NMR of compound 2 
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Figure 18. 1H NMR of compound 3 
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Figure 19. 13C NMR of compound 3 
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 Figure 20. 1H NMR of compound 4 
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Figure 21. 13C NMR of compound 4 
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Figure 22. 1H NMR of compound 5 
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 Figure 23. 13 C  NMR of compound 5 
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Figure 24. 1H NMR of compound 6 
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Figure 25. 13C NMR of compound 6 
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Figure 26. 1H NMR of compound 7 
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Figure 27. 13C NMR of compound 7 
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Figure 28. 1H NMR of compound 8 
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Figure 29. 13C NMR of compound 8 
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Figure 30. 1H NMR of compound 10 
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Figure 31. 13C NMR of compound 10 
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Figure 32. 1H NMR of compound 11 
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Figure 33. 13C  NMR of compound 11 
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Figure 34. 1H NMR of compound 12 
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Figure 35. 13C  NMR of compound 12 
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Figure 36. 1H NMR of compound 13 
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Figure 37.  13C NMR of compound 13 
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Figure 38. 1H NMR of compound 14 
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Figure 39. 13C NMR of compound 14 
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Figure 40. 1H NMR of compound 15 
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Figure 41. 13C NMR of compound 15 
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 Figure 42. 1H NMR of compound 16 
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Figure 43.  DEPT NMR of compound 16 
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Figure 44.  1H NMR of compound 17 
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Figure 45. 13C  NMR of compound 17 
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Figure 46. DEPT NMR of compound 18 
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Figure 47. 1H NMR of compound 19 
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Figure 48. 13C NMR of compound 19 
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Figure 49. 1H NMR of compound 20 
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Figure 50. 13C  NMR of compound 20 
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Figure 51. 1H NMR of compound 21 
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Figure 52. 13 CNMR of compound 21 
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Figure 53. 1H NMR of compound 22 
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 Figure 54. 1H NMR of compound 23 
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 Figure 55. 13C NMR of compound 26 
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Figure 56. 1H NMR of compound 28 
 
 
 
Figure 57. 1H NMR of compound 29 
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Figure 58. 1H NMR of compound 30 
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Figure 59. 1H NMR of compound 31 
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Figure 60. 13C  NMR of compound 31 
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Figure 61. 1H NMR of compound 33 
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Figure 62. 1H NMR of compound 34 
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Figure 63. 1H NMR of compound 35 
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Figure 64. 1H NMR of compound 36 
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